4//SEC Filing
OSIRIS THERAPEUTICS, INC. 4
Accession 0001179110-15-004506
CIK 0001360886operating
Filed
Mar 8, 8:00 PM ET
Accepted
Mar 9, 4:00 PM ET
Size
7.4 KB
Accession
0001179110-15-004506
Insider Transaction Report
Form 4
Debrabandere Lode
Vice President
Transactions
- Award
Incentive Stock Option (right to buy)
2015-03-06$18.40/sh+5,434$99,986→ 377,934 totalExercise: $18.40From: 2016-03-06Exp: 2025-03-06→ Common Stock (5,434 underlying) - Award
Non-Qualified Stock Option (right to buy)
2015-03-06$18.40/sh+69,566$1,280,014→ 447,500 totalExercise: $18.40From: 2016-03-06Exp: 2025-03-06→ Common Stock (69,566 underlying)
Footnotes (1)
- [F1]Options to purchase 75,000 shares of the common stock of the Registrant shall become exercisable with respect to the underlying shares as to 25% on each March 6, 2016, 2017, 2018 and 2019, assuming the Reporting Person continues to be employed by the Registrant on the vesting date.
Documents
Issuer
OSIRIS THERAPEUTICS, INC.
CIK 0001360886
Entity typeoperating
IncorporatedMD
Related Parties
1- filerCIK 0001360886
Filing Metadata
- Form type
- 4
- Filed
- Mar 8, 8:00 PM ET
- Accepted
- Mar 9, 4:00 PM ET
- Size
- 7.4 KB